Glucagon regulates hepatic lipid metabolism via cAMP and Insig-2 signaling: Implication for the pathogenesis of hypertriglyceridemia and hepatic steatosis

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Wang, Hai ^a   Zhao, Miaoyun ^a   Sud, Neetu ^a   Christian, Patricia ^a   Shen, Jing ^a   Song, Yongyan ^a   Pashaj, Anjeza ^a   Zhang, Kezhong ^b   Carr, Timothy ^a   Su, Qiaozhu ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREB3L3 PROTEIN, MOUSE; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUCAGON; INSIG2 PROTEIN, MOUSE; MEMBRANE PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ANIMAL; C57BL MOUSE; DRUG EFFECT; FATTY LIVER; GENETICS; HEP-G2 CELL LINE; HUMAN; HYPERTRIGLYCERIDEMIA; KNOCKOUT MOUSE; LIPID METABOLISM; LIPOGENESIS; LIVER CELL; METABOLISM; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; FATTY LIVER; GLUCAGON; HEP G2 CELLS; HEPATOCYTES; HUMANS; HYPERTRIGLYCERIDEMIA; LIPID METABOLISM; LIPOGENESIS; MEMBRANE PROTEINS; MICE, INBRED C57BL; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

EID: 84984918832     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep32246     Document Type: Article

References (41)

1. M. J. Dekker et al. "Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome," Am. J. Physiol Endocrinol. Metab 299(5), E685-E694 (2010).
2. Qiaozhu, Su et al. "Apolipoprotein B: not just a biomarker but a causal factor in hepatic endoplasmic reticulum stress and insulin resistance," 5(2), 267 (2010).
3. Y. A. Moon et al. "The Scap/SREBP pathway is essential for developing diabetic fatty liver and carbohydrate-induced hypertriglyceridemia in animals," Cell Metab 15(2), 240 (2012).
4. J. J. Tang et al. "Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques," Cell Metab 13(1), 44 (2011).
5. D. Yabe et al. "Liver-specific mRNA for Insig-2 down-regulated by insulin: implications for fatty acid synthesis," Proc. Natl. Acad. Sci. USA 100(6), 3155 (2003).
6. M. S. Brown & J. L. Goldstein. "Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADL," J. Lipid Res. 50 Suppl, S15-S27 (2009).
7. A. Fernandez-Alvarez et al. "Characterization of the human insulin-induced gene 2 (INSIG2) promoter: the role of Ets-binding motifs," J. Biol. Chem. 285(16), 11765 (2010).
8. G. Bobe et al. "Effects of exogenous glucagon on lipids in lipoproteins and liver of lactating dairy cows," J. Dairy Sci. 86(9), 2895 (2003).
9. R. A. Nafikov et al. "Prevention of fatty liver in transition dairy cows by subcutaneous injections of glucagon," J. Dairy Sci. 89(5), 1533 (2006).
10. A. Charbonneau et al. "Evidence of hepatic glucagon resistance associated with hepatic steatosis: reversal effect of training," Int. J. Sports Med. 26(6), 432 (2005).
11. A. Charbonneau et al. "Alterations in hepatic glucagon receptor density and in Gsalpha and Gialpha2 protein content with dietinduced hepatic steatosis: effects of acute exercise," Am. J. Physiol Endocrinol. Metab 289(1), E8 (2005).
12. C. Longuet et al. "The glucagon receptor is required for the adaptive metabolic response to fasting," Cell Metab 8(5), 359 (2008).
13. M. Lu & J. Y. Shyy. "Sterol regulatory element-binding protein 1 is negatively modulated by PKA phosphorylation," Am. J. Physiol Cell Physiol 290(6), C1477-C1486 (2006).
14. T. Yamamoto et al. "Protein kinase A suppresses sterol regulatory element-binding protein-1C expression via phosphorylation of liver X receptor in the liver," J. Biol. Chem. 282(16), 11687 (2007).
15. K. Zhang et al. "Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response," Cell 124(3), 587 (2006).
16. J. Luebke-Wheeler et al. "Hepatocyte nuclear factor 4alpha is implicated in endoplasmic reticulum stress-induced acute phase response by regulating expression of cyclic adenosine monophosphate responsive element binding protein H," Hepatology 48(4), 1242 (2008).
17. J. D. Horton, J. L. Goldstein & M. S. Brown. "SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver," J. Clin. Invest 109(9), 1125 (2002).
18. H. Danno et al. "The liver-enriched transcription factor CREBH is nutritionally regulated and activated by fatty acids and PPARalpha," Biochem. Biophys. Res. Commun. 391(2), 1222 (2010).
19. C. L. Gentile et al. "Fatty acids regulate CREBh via transcriptional mechanisms that are dependent on proteasome activity and insulin," Mol. Cell Biochem. 344(1-2), 99 (2010).
20. A. H. Lee. "The role of CREB-H transcription factor in triglyceride metabolism," Curr. Opin. Lipidol. 23(2), 141 (2012).
21. J. H. Lee et al. "The transcription factor cyclic AMP-responsive element-binding protein H regulates triglyceride metabolism," Nat. Med. 17(7), 812 (2011).
22. D. Yabe, M. S. Brown & J. L. Goldstein. "Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins," Proc. Natl. Acad. Sci. USA 99(20), 12753 (2002).
23. Y. L. Zhang et al. "Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis," J. Biol. Chem. 281(49), 37603 (2006).
24. X. Tong et al. "Activation of hepatic CREBH and Insig signaling in the anti-hypertriglyceridemic mechanism of R-alpha-lipoic acid," J. Nutr. Biochem. 26(9), 921 (2015).
25. N. Sever et al. "Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain," Mol. Cell 11(1), 25 (2003).
26. X. Xu et al. "Transcriptional regulation of apolipoprotein A-IV by the transcription factor CREBH," J. Lipid Res. 55(5), 850 (2014).
27. H. L. Kammoun et al. "GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice," J. Clin. Invest 119(5), 1201 (2009).
28. Y. Gong. et al. "Juxtamembranous aspartic acid in Insig-1 and Insig-2 is required for cholesterol homeostasis," Proc. Natl. Acad. Sci. USA 103(16), 6154 (2006).
29. Y. Gong et al. "Sterol-regulated ubiquitination and degradation of Insig-1 creates a convergent mechanism for feedback control of cholesterol synthesis and uptake," Cell Metab 3(1), 15 (2006).
30. T. Kakuma et al. "Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets," Proc. Natl. Acad. Sci. USA 97(15), 8536 (2000).
31. K. Takaishi et al. "Hepatic insig-1 or -2 overexpression reduces lipogenesis in obese Zucker diabetic fatty rats and in fasted/refed normal rats," 101(18) (2004).
32. A. Herbert et al. "A common genetic variant is associated with adult and childhood obesity," Science 312(5771), 279 (2006).
33. S. B. Joseph et al. "Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors," J. Biol. Chem. 277(13), 11019 (2002).
34. M. T. Bengoechea-Alonso & J. Ericsson. "A phosphorylation cascade controls the degradation of active SREBP1," J. Biol. Chem. 284(9), 5885 (2009).
35. M. T. Bengoechea-Alonso, T. Punga & J. Ericsson. "Hyperphosphorylation regulates the activity of SREBP1 during mitosis," Proc. Natl. Acad. Sci. USA 102(33), 11681 (2005).
36. C. R. Yellaturu et al. "Insulin enhances post-translational processing of nascent SREBP-1c by promoting its phosphorylation and association with COPII vesicles," J. Biol. Chem. 284(12), 7518 (2009).
37. S. Herzig et al. "CREB controls hepatic lipid metabolism through nuclear hormone receptor PPAR-gamma," Nature 426(6963), 190 (2003).
38. Q. Su et al. "Apolipoprotein B100 acts as a molecular link between lipid-induced endoplasmic reticulum stress and hepatic insulin resistance," Hepatology 50(1), 77 (2009).
39. Q. Su et al. "Hepatic mitochondrial and ER stress induced by defective PPARalpha signaling in the pathogenesis of hepatic steatosis," Am. J. Physiol Endocrinol. Metab (2014).
40. J. N. Lee & J. Ye. "Proteolytic activation of sterol regulatory element-binding protein induced by cellular stress through depletion of Insig-1," J. Biol. Chem. 279(43), 45257 (2004).
41. J. Taher et al. "GLP-1 receptor agonism ameliorates hepatic VLDL overproduction and de novo lipogenesis in insulin resistance," Mol. Metab 3(9), 823 (2014).